Rhythm Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $54.3M | $89.1M | $60.1M | $127.7M | $59.2M | $100.9M | $62.3M | $49.5M |
| Accounts Receivable | $26.1M | $18.5M | $14.9M | $6.2M | $1.0M | — | — | — |
| Inventory | $25.8M | $18.7M | $8.6M | $2.9M | $111.0K | — | — | — |
| Total Current Assets | $466.9M | $374.2M | $308.3M | $354.2M | $308.4M | $181.7M | $302.4M | $258.7M |
| Property, Plant & Equipment | $1.1M | $632.0K | $1.3M | $2.2M | $2.8M | $3.2M | $3.7M | $1.1M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $5.3M | $6.2M | $7.0M | $7.9M | $4.7M | — | — | — |
| Total Assets | $480.2M | $392.3M | $332.7M | $382.5M | $329.5M | $187.1M | $308.5M | $260.2M |
| Liabilities | ||||||||
| Accounts Payable | $13.9M | $12.3M | $4.9M | $4.8M | $5.7M | $4.9M | $10.4M | $7.6M |
| Total Current Liabilities | $105.9M | $115.5M | $55.2M | $39.8M | $43.4M | $18.0M | $24.4M | $13.6M |
| Long-Term Debt | $100.9M | $108.3M | $106.1M | — | — | — | — | — |
| Total Liabilities | $210.2M | $227.7M | $163.0M | $118.2M | $45.4M | $20.5M | $27.5M | $14.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.35B | $-1.16B | $-894.7M | $-710.1M | $-528.9M | $-459.3M | $-325.3M | $-184.6M |
| Total Stockholders' Equity | $139.1M | $21.7M | $169.8M | $264.3M | $284.2M | $166.5M | $281.0M | $246.3M |